Dupixent® (dupilumab) is now approved in India for the treatment of adults with moderate-to-severe atopic dermatitis
Dupixent® (dupilumab) is now approved in India for the treatment of adults with moderate-to-severe …
Dupixent® (dupilumab) is now approved in India for the treatment of adults with moderate-to-severe …
Mankind , Cancer , Innovent , India , Pharma , Sintilimab , Market , Across , Innovative , Patients…